Replies to post #87150 on Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Licensing deal or development partnership with Becton Dickinson is what will really propel the share price higher.

Today's news put the market on noticed and cemented support in the .065 range.

Expecting another valuation article from Jason Napadano very soon.

News on other topics also expected: i.e. second orphan indication for MANF and possible Novartis news.

"Patience is a virtue."


All IMHO.